ProfileGDS5678 / 1425174_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 58% 57% 57% 58% 60% 60% 58% 58% 58% 58% 58% 57% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5085257
GSM967853U87-EV human glioblastoma xenograft - Control 23.4892858
GSM967854U87-EV human glioblastoma xenograft - Control 33.447557
GSM967855U87-EV human glioblastoma xenograft - Control 43.3967557
GSM967856U87-EV human glioblastoma xenograft - Control 53.4576658
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6618560
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6860760
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4888158
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4715558
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.483458
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4723458
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4656258
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.479557
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4862758